
Alvopetro Energy Ltd completes Brazil gas plant upgrade as September sales fall
A five-day shutdown reduced September deliveries, while the upgraded UPGN-Caburé plant can process more Murucututu gas.

The Quebec grower has 15 of 24 Valleyfield rooms active and is still pursuing EU-GMP certification for its own processing centre.

A five-day shutdown reduced September deliveries, while the upgraded UPGN-Caburé plant can process more Murucututu gas.

Seraxis notes are expected to convert into BetaNova stock if the merger closes; the first SR-02 patient dose is targeted for Q1 2027.
The designation offers prioritized FDA interaction, while a pivotal study and separate clearance submission still lie ahead.
The exchange cited a US$15M market value rule; ESS says shares remain in holders' accounts and plans to request review.

The Oct. 5 filing shows 29,462 bitcoin held on Oct. 2 as effective common and preferred share counts both rose over the prior week.

The Oct. 1 release says Inferize engineers joined Token Factory but gives no purchase price, integration timetable or sales target.

The planned notice would lift cash to US$1 and the cap to US$6 per share, and extend the current Dec. 1 expiry to Dec. 4.

The Oct. 5 release says Galam's first doré bar came from Merrill-Crowe cement, but gives neither the bar's weight nor a date for the pilot to reach nameplate capacity.
The North American agreement names no purchase value or delivery schedule as LG prepares a Virginia chiller plant for first-half 2027 production.
The agreed purchase includes Terra Nova and White Rose interests, with closing targeted for the first half of 2027.
The Oct. 5 sale leaves 38.3 million previously issued shares unsold as the company targets a £17 million Coinbase loan balance.
E.ON expects to match the EU grid grant with nearly HUF230B of its own spending across a four-year network program.
The four-year plan covers existing lines in three states, but Entergy has given no installation start date or full project budget.
Two unnamed inference customers extend earlier deals, with QumulusAI targeting capacity turnover in December 2026 and early 2027.
Among 109 treated patients, the median response lasted 12.1 months; the single-arm cohort offers no direct efficacy comparison.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The two-year agreement calls for US$600,000 in shares and US$225,000 in cash, subject to TSX Venture Exchange acceptance.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Stoke plans to combine four Vineland-3 subdomains for its U.S. NDA after a Phase 3 readout expected in the third quarter of 2027.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
The Sept. 29 plan gives cannabis operators no deadline or estimate of tax relief as the guidance project enters the new fiscal year.
The second 500 MW phase is now planned for 2029, but Kentucky commission approval and the utility's construction schedule still govern delivery.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Minnesota's attorney general says Xcel has not shown its Google agreement protects other customers from service and stranded costs.

The Nevada lithium study assumes US$24,000 per tonne of lithium carbonate and US$2.77 billion in first-phase capital.

TVA's Clinch River permit took effect Sept. 28; GE Vernova's Sept. 29 release states no equipment price or delivery date.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Congress delayed the new 0.4-milligram finished-product threshold to Dec. 11, leaving Tilray's disclosed U.S. drink formats above it.

State approvals cleared the Oct. 1 transfer of certain Ohio operations; AYR disclosed no cash proceeds or debt relief figure.

One petition is active and the other pending review; both would let Florida medical operators sell to adults if voters approve.

The ARTG's Sept. 15 entry names Jupiter Research as manufacturer; Curaleaf also reports a Sept. 17 New Zealand WAND notification.